Diagnostic value of flow mediated dilatation measurement for coronary artery lesions in men under 45 years of age

Cardiology Journal

Volumn 17, Issue 3, 2010, Pages 288-292

  Kaźmierski, Maciej ^a   Michalewska Włudarczyk, Aleksandra ^a   Krzych, Lukasz J ^a   Tendera, Michał ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Coronary artery disease; Endothelial dysfunction; Flow mediated dilatation

Indexed keywords

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR PROCEDURES; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FAMILY HISTORY; FLOW MEDIATED DILATATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; ANGIOCARDIOGRAPHY; BLOOD FLOW; BRACHIAL ARTERY; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CORONARY ARTERY BLOOD FLOW; CORONARY STENOSIS; DIAGNOSTIC USE; HYPEREMIA; MIDDLE AGED; PATHOPHYSIOLOGY; POLAND; PREDICTIVE VALUE; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; RISK; STATISTICAL MODEL; VASCULAR ENDOTHELIUM; VASODILATATION;

GLYCERYL TRINITRATE; VASODILATOR AGENT;

BRACHIAL ARTERY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; ENDOTHELIUM, VASCULAR; HUMANS; HYPEREMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; NITROGLYCERIN; ODDS RATIO; POLAND; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; VASODILATION; VASODILATOR AGENTS;

EID: 77953449229     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Multiple Risk Factors Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factors Intervention Trial: Findings related to a priori hypothesis of the trial. JAMA, 1990; 263: 1795-1801.
2. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation, 1997; 96: 3390-3395.
3. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilatation of coronary resistance vessels is associated with exercise-induced ischemia. Circulation, 1995; 91: 2345-2352.
4. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med, 1990; 323: 27-36.
5. Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. International Brachial Artery Reactivity Task Force. J Am Coll Cardiol, 2002; 39: 257-265.
6. Anggard EE. The endothelium - the body's largest endocrine gland? J Endocrinol, 1990; 127: 371-375.
7. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 1992; 340: 1111-1115.
8. Joannides R, Haefeli WE, Linder L et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation, 1995; 91: 1314-1319.
9. Lieberman EH, Gerhard MD, Uehata A et al. Flow-induced vasodilatation of the human brachial artery is impaired in patients < 40 years of age with coronary artery disease. Am J Cardiol, 1996; 78: 1210-1214.
10. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol, 1994; 24: 1468-1474.
11. Mombouli JV, Vanhoutte PM. Endothelial dysfunction: From physiology to therapy. J Mol Cell Cardiol, 1999; 31: 61-74.
12. Corretti MC, Plotnick GD, Vogel RA. Correlation of cold pressor and flow-mediated brachial artery diameter responses with the presence of coronary artery disease. Am J Cardiol, 1995; 75: 783-787.
13. Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R, Patsch JR. Flow-mediated vasodilatation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men. J Am Coll Cardiol, 2001; 38: 1313-1319.
14. Kuvin JT, Patel AR, Sliney KA et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol, 2001; 38: 1843-1849.
15. Kuvin JT, Patel AR, Sidhu M et al. Relation between high-density lipoprotein cholesterol and peripheral vasomotor function. Am J Cardiol, 2003; 92: 275-279.
16. Patel AR, Kuvin JT, Sliney KA et al. Gender-based differences in brachial artery flow-mediated vasodilatation as an indicator of significant coronary artery disease. Am J Cardiol, 96: 1223--1226.
17. Neunteufl T, Katzenschlager R, Hassan A et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis, 1997; 129: 111-118.
18. Kirma C, Akcakoyun M, Esen AM et al. Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circ J, 2007; 71: 698-702.
19. Herrington DM, Fan L, Drum M et al. Brachial flow-mediated vasodilator responses in population-based research: Methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk, 2001; 8: 319-328.
20. Rissanen AM, Nikkilä EA. Coronary artery disease and its risk factors in families of young men with angina pectoris and in controls. Br Heart J, 1977; 39: 875-883.